Watch Presentation:
From Evidence to Access: Understanding Payer Decisions and Rethinking Engagement

From Evidence to Access: Understanding Payer Decisions and Rethinking Engagement

Thursday, October 22, 2026

Clinical evidence is only one part of the payer decision-making process. Coverage and access decisions may also reflect economic, operational, contracting, and other considerations that shape how pharmaceuticals and medical devices are evaluated.

Join Magnolia Market Access for a discussion on how payers make coverage and access decisions, what influences those decisions, and how manufacturers can better align evidence and engagement with payer needs.

Why Watch:
In this session, listen to better understand payer decision-making and explore how evidence and engagement can support more informed access discussions, including:

  • How payer organizations evaluate coverage and access decisions across pharmaceuticals and medical devices
  • The evidence, stakeholder perspectives, and other inputs that can influence payer decision-making
  • Approaches to payer engagement that help deliver relevant information to the right decision-makers
View Presentation

Panelists include: